The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 17, 2018

Filed:

Aug. 21, 2015
Applicant:

Momenta Pharmaceuticals, Inc., Cambridge, MA (US);

Inventors:

Carlos J. Bosques, Arlington, MA (US);

Jennifer Murphy, Marshfield, MA (US);

Hetal Sarvaiya, Quincy, MA (US);

Nathaniel Washburn, Littleton, MA (US);

Cuihua Liu, Belmont, MA (US);

Xiao-Jin Xu, Southborough, MA (US);

Assignee:

Momenta Pharmaceuticals, Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12P 21/00 (2006.01); G01N 33/53 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
C12P 21/005 (2013.01); C07K 14/70521 (2013.01); G01N 33/5308 (2013.01); C07K 2319/30 (2013.01); G01N 2400/02 (2013.01); Y10T 436/24 (2015.01); Y10T 436/25 (2015.01); Y10T 436/25125 (2015.01); Y10T 436/25375 (2015.01);
Abstract

Methods of producing recombinant therapeutic fusion proteins described herein can include culturing Chinese hamster ovary (CHO) cells under conditions suitable for expression of a recombinant therapeutic fusion protein including one or more glycans, where the CHO cells have not been genetically engineered to produce terminal alpha-galactosyl residues on glycans; treating the one or more glycans of the recombinant glycoprotein with one or more exoglycosidases; measuring glycans containing terminal galactose-alpha-1-3-galactose residues on the fusion protein by nuclear magnetic resonance (NMR); and producing a recombinant therapeutic fusion protein in the CHO cells if a target level of terminal galactose-alpha-1-3-galactose residues is measured.


Find Patent Forward Citations

Loading…